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Background: Enlargement of the left atrium (LA) is a risk factor of atrial ﬁbrillation (AF) recurrence after
pharmacological and nonpharmacological interventions for AF. However, structural changes associated
with LA enlargement have not been fully elucidated.
Methods: To examine inﬂammation in the structural changes associated with LA enlargement, human
left appendages obtained from 27 patients who underwent cardiac surgery by using the maze procedure
were subjected to immunohistochemical analysis.
Results: The extent of interstitial ﬁbrosis increased according to the increase in LA dimension (LAD) as
assessed by using ultrasound echocardiography. The extent of the inﬁltration of CD68-positive macro-
phages and CD3-positive T cells increased simultaneously according to the increments in LAD. The areas
inﬁltrated by immune cells were positively and signiﬁcantly correlated with LAD (r2¼0.58, po0.01 for
CD68; r2¼0.49, po0.01 for CD3).
Conclusions: In the patients with AF, LA enlargement was associated not only with the increase in the
extent of interstitial ﬁbrosis but also with the changes in the LA component cells, including an increase in
number of immune cells resident in tissues.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Atrial ﬁbrillation (AF), the most common type of sustained
tachyarrhythmia, affecting approximately 0.9% of the population,
is known to be associated with signiﬁcant morbidity and mortality
[1–4]. Recently, circumferential pulmonary vein isolation (CPVI)
via catheter ablation has been established as a curative strategy for
this type of arrhythmia, suggesting an important role of the
thoracic veins in the mechanisms underlying AF. However, the
success rate of CPVI ablation has been reported to decrease with
increases in left atrial dimension (LAD) [5–7], similar to that of
pharmacotherapy. This suggests potential pathological processes
that invade the atrium from the pulmonary veins in a progressive
manner in concert with the enlargement of the left atrium (LA).
A substantial body of evidence linking inﬂammation to the
pathophysiology of a broad spectrum of cardiovascular diseases,
including coronary artery disease, diabetes mellitus, and
hypertension, has been developed [8–11]. Similarly, the hypothesis
that inﬂammatory processes are involved in the pathogenesis of AF
has attracted renewed attention. In previous studies, other research-
ers and we demonstrated the recruitment of immune cells across
the atrial endocardium in patients with AF [12,13]; however, the
degree of inﬁltration of immune cells widely varied between patients.
In the present study, we hypothesized that inﬂammatory
processes occur and progress according to LA enlargement, which
may contribute in part to the refractoriness to interventions for AF
with an enlarged LA. Atrial appendage specimens from patients
with AF who had undergone cardiac surgery were used for
immunohistochemical analysis to assess potential relationships
between LAD and the inﬁltration of immune cells.
2. Materials and methods
2.1. Patients
Left atrial appendage specimens were obtained from patients
who had undergone cardiac surgery involving the maze
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/joa
Journal of Arrhythmia
http://dx.doi.org/10.1016/j.joa.2014.07.003
1880-4276/& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
n Corresponding author. Tel.: þ81 3 3408 2151; fax: þ81 3 3401 2159.
E-mail address: yamt-tky@umin.ac.jp (T. Yamashita).
Journal of Arrhythmia 31 (2015) 78–82
procedure. LAD was evaluated based on transthoracic echocardio-
grams obtained within 1 week before the operation. All the
patients had AF (persistent AF, 21; paroxysmal AF, 6). None of
the patients had a previous myocardial infarction, febrile disor-
ders, systemic inﬂammatory diseases, malignancy, or chronic renal
failure. This investigation conformed to the principles outlined in
the Declaration of Helsinki and was approved by an institutional
review board (2005/7/13), and written informed consent was
obtained from all the patients.
2.2. Histological examination and immunohistochemistry
Blocks of tissues were embedded in optimal cutting tempera-
ture compound and immediately frozen in liquid nitrogen after
resection. Frozen cryostat sections (8 mm) were cut, air-dried, ﬁxed
in acetone, and thereafter evaluated with standard protocols for
staining with hematoxylin–eosin and Masson trichrome stain.
Immunostaining was performed in sequential sections by using
Dako EnVisionþSystems (Dako) with primary antibodies for CD68
(KT117, TransGenic, Inc.) and CD3 (Nichirei Bioscience 413591).
Inﬁltration of immune cells in the atrium was examined via
light microscopy by using immunostained images at a magniﬁca-
tion of 100 captured with a digital camera (Nikon). Using the
Image-Pro Plus software (Media Cybernetics, Carlsbad, CA, USA),
the extent (% area) of interstitial ﬁbrosis and positive staining
representing immunoreactivity was recorded and corrected to the
total section areas. The mean value was obtained from 10 different
ﬁelds selected blindly for each patient.
2.3. Statistical analysis
Data were expressed as mean7SD values. Correlations of LAD
to interstitial ﬁbrosis and immunoreactive areas were evaluated by
using linear regression analysis. Statistical signiﬁcance was set at a
po0.05.
Fig. 1. (A) Masson-trichrome staining of left atrial appendage specimens from patients with left atrial dimensions (LADs) of 43 mm (left), 59 mm (middle), and 67 mm
(right), respectively. The extent of interstitial ﬁbrosis (blue area) increased as the LAD increased. (B) Correlation between LAD (mm) and ﬁbrosis area (% of the total section
area). A statistically signiﬁcant positive correlation was observed.
Table 1
Patient characteristics.
n (%)
Male/female 17/10
Age (years), mean7SD 59.9710.1
EF (%), mean7SD 63.479.2
LAD (mm), mean7SD 55.2711.0
Paroxysmal (%) 6 (22.2)
AF duration (months), mean7SD 82.4779.9
Concomitant heart diseases
MR 16 (59)
MRþTR 3 (11)
MRþAR/AS 3 (11)
AR/AS 3 (11)
ASD 2 (7)
Medications
VKA 27 (100)
Diuretics 26 (96)
RAS inhibitor 17 (63)
Beta-blocker 16 (59)
EF, ejection fraction; LAD, left atrial dimension; VKA, vitamin K
antagonist; RAS, renin-angiotensin system; MR, mitral regurgita-
tion; TR, tricuspid regurgitation; AR, aortic regurgitation; AS, aortic
stenosis; and ASD, atrial septal defect.
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3. Results
Table 1 shows the characteristics of the 27 patients in the
present study from whom left atrial appendage specimens were
obtained. Of the 27 patients, 17 were men, and the mean patient
age was 59.9710.1 years. The mean AF duration was 82.4779.9
months. Cardiac surgeries were performed for mitral regurgitation
with/without mitral stenosis in 19 patients, aortic regurgitation
with/without stenosis in 3 patients, combined valvular diseases in
3 patients, and atrial septal defect in 2 patients. The ejection
fraction as assessed by using echocardiography ranged from 50% to
80% (mean7SD, 63.479.2%), and the LAD ranged from 28 to
80 mm (mean7SD, 55.2711.0 mm). Before the operations, all the
patients received warfarin for anticoagulation. Loop diuretics were
prescribed in 26 patients (96%), renin-angiotensin system blockers
in 17 (63%), and beta-blockers in 16 (59%). Just before the
operation, 6 patients with a history of paroxysmal AF were in
sinus rhythm, and the remaining 21 patients were with persistent
AF.
The extent of interstitial ﬁbrosis, including subendocardial and
perivascular ﬁbroses, determined on Masson-trichrome staining,
varied widely in these patients. The interstitial ﬁbrotic area
increased progressively according to the increments of LAD
(Fig. 1A). A statistically signiﬁcant positive correlation was
observed between LAD and the % area of interstitial ﬁbrosis
(Fig. 1B, r2¼0.44, po0.01).
As observed in our previous study [12], immunohistochemical
analysis with the macrophage-speciﬁc CD68 antibody revealed the
inﬁltration of inﬂammatory immune cells, with dominant distri-
bution in the subendocardium (Fig. 2A). The degree of inﬁltration
varied among patients; however, when we aligned the images
from the patients with smaller to larger LADs, the magnitude of
the macrophage inﬁltration showed a parallel increase (Fig. 2A).
The CD68 immunostaining area increased according to the incre-
ments of LAD, and a signiﬁcant positive correlation between LAD
and the CD68 immunostaining area was detected (Fig. 2B, r2¼0.58,
po0.01). CD3-positive T cells were observed to inﬁltrate into the
atrium, although to a lesser extent than macrophages (Fig. 3A). A
signiﬁcant positive correlation between the LAD and the CD3
immunostaining area was also detected (Fig. 3B, r2¼0.49,
po0.01).
4. Discussion
The major ﬁndings of the present study were that the extent of
interstitial ﬁbrosis increased as LA enlarged (as shown in previous
studies [12–14]) and that the inﬁltration of immune cells, includ-
ing macrophages and T cells, also increased in concert with LA
enlargement.
Proinﬂammatory macrophages and T cells are known to con-
tribute substantially to the progression of various cardiovascular
diseases [8–11]. They include atherosclerosis, myocardial infarc-
tion, congestive heart failure, and recently, AF [12,13]. In athero-
sclerosis, activated macrophages are known to transmigrate across
the endothelium and make critical contributions to lesion forma-
tion by secreting a variety of proinﬂammatory cytokines [8].
However, the mechanism by which the inﬂammatory cells parti-
cipate chronically in the progression of other cardiac diseases such
as AF remains unclear. Descriptive results from our previous study
Fig. 2. (A) CD68 immunostaining of the left atrium from the same patients presented in Fig. 1. High number of immunostained macrophages (brown area) were observed as
left atrial dimension (LAD) increased. (B) Correlation between LAD (mm) and the CD68-immunostained area (% of the total section area). A statistically signiﬁcant positive
correlation was observed.
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[12] demonstrated the recruitment of immune cells across the
endocardium of the LA in patients with AF, suggesting the
existence of chronic inﬂammation in the atrium. Despite these
results, the cause-and-effect relationships in AF remain uncertain.
A recent meta-analysis has shown that an enlarged LA
increases the risk of AF recurrence after a single CPVI, regardless
of the follow-up duration [5]. This ﬁnding can be applied to
paroxysmal and persistent AF [6,7]. In clinical practice, measure-
ment of LAD can provide a window into the status of the structural
remodeling of LA and may inﬂuence the ablation strategy. How-
ever, the pathophysiological mechanisms connecting a dilated LA
to postablation AF recurrence are not fully understood.
One plausible mechanism involves atrial interstitial ﬁbrosis, as
it could slow the intra-atrial conduction inhomogeneously, leading
to reentry in LA [14]. By demonstrating that LAD was correlated
positively with the interstitial ﬁbrosis deposits in the LA, the
results of the present study support this hypothesis. A second
plausible mechanism involves C-reactive protein (CRP) [15], as a
study revealed that CRP level was an independent risk factor of AF
recurrences after ablation and was also associated with LA
enlargement. In the present study, we observed immunohisto-
chemical evidence that supports the results of the CRP clinical
study on the basis that the inﬁltration of immune cells into LA
represented a local inﬂammatory response. However, it should be
noticed that the present results cannot be extrapolated directly to
patients with AF without structural heart diseases; therefore,
future investigations are required.
A potential limitation of the present study was the lack of
information owing to ethical issues regarding patients without
structural heart diseases. Therefore, it may be argued that the
observations regarding local inﬂammation in the atrium could be
applied to patients with AF without valvular diseases. Second, only
left atrial appendage samples were available; therefore, our ﬁnd-
ings may not represent other areas of the atrium. Lastly, the
number of patients examined was relatively small. Although
limited for these reasons, the results of the present study provide
new data regarding the pathophysiological signiﬁcance of
enlarged LA in patients with AF by demonstrating the relation-
ships between LAD and the inﬁltration of immune cells. However,
elucidation of the precise roles of the immune cells inﬁltrating into
the enlarged atrium will require further investigations.
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